我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的隐私政策。
相关临床试验
27
2 进行中
药物批准
0
批准总数
监管机构
监管机构数
成立时间
2003
进行中（未招募）
2
7.4%
已完成
16
59.3%
招募中
1
3.7%
终止
4
14.8%
Unknown
3
11.1%
撤回
暂无批准数据
- ImmunityBio has agreed to a revised lease with New York State for the Dunkirk pharmaceutical facility, increasing annual rent from $1 to $525,000 and committing to $40 million in capital improvements. - The company must hire at least 100 employees by the end of 2028 and scale to 450 employees by 2032, representing a more realistic timeline compared to the failed Athenex agreement. - The new one-year renewable lease structure allows annual compliance assessments, with stricter accountability measures following nearly a decade of uncertainty at the state-funded facility.
